StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$46.55+0.42 (+0.91%)

Close on Oct 19, 2026Market cap –P/E 24.0Yield 0.54%

Qiagen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 219M, down 2.6% from the year before. Over ten years it grew -0.9% a year on average. The highest annual figure on record is 243M in fiscal 2014.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025219M-2.6%
FY2024Dec 31, 2024225M-2.6%
FY2023Dec 31, 2023231M+0.2%
FY2022Dec 31, 2022230M-0.8%
FY2021Dec 31, 2021232M-0.9%
FY2020Dec 31, 2020234M+3.3%
FY2019Dec 31, 2019227M-2.9%
FY2018Dec 31, 2018233M+0.2%
FY2017Dec 31, 2017233M-2.5%
FY2016Dec 31, 2016239M+0.1%
FY2015Dec 31, 2015239M-1.7%
FY2014Dec 31, 2014243M+0.3%
FY2013Dec 31, 2013242M+0.6%
FY2012Dec 31, 2012241M+0.7%
FY2011Dec 31, 2011239M-0.6%
FY2010Dec 31, 2010240M+12.6%
FY2009Dec 31, 2009214M+4.6%
FY2008Dec 31, 2008204M–

More Qiagen figures

See a number that looks wrong?